<DOC>
	<DOCNO>NCT03007537</DOCNO>
	<brief_summary>To testify prevention Erythropoietin cardiac surgery associated-acute kidney injury , try provide evidence protect renal function improve prognosis patient cardiac surgery .</brief_summary>
	<brief_title>The Prevention Erythropoietin Cardiac Surgery-associated Acute Kidney Injury</brief_title>
	<detailed_description>Patients meet inclusion criterion agree sign inform consent randomly assign control group erythropoietin group.Interventions apply 1 day ( 24hrs ) cardiac surgery . Blood Urine sample collect surgery . By use criterion give KDIGO2012 test biomarkers acute kidney injury , hope find association erythropoietin administration occurence acute kidney injury .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>1 . Preoperative hemoglobinï¼œ130g/L ; 2 . Surgery : valve , coronary artery bypass graft surgery congenital heart diseases ; 3 . Volunteers inform consent . 1 . Patients combined infection ; 2 . Patients endstage renal disease undergoing renal replacement therapy 3 . Patients history thromboembolism ; 4 . Patients malignant tumor undergoing chemotherapy ; 5 . Patients unmanageable hypertension ( systolic pressure &gt; 200 mmHg diastolic pressure &gt; 110mmHg ) ; 6 . Patients allergic erythropoietin ; 7 . Patients inject erythropoietin within 2 week .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Erythropoietin</keyword>
	<keyword>Cardiac Surgery Associated-acute Kidney Injury</keyword>
</DOC>